Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis

Inclusion Criteria: * Patients who have mild to moderate ulcerative colitis, with a current Partial Mayo Index greater than or equal to 2 and less than or equal to 6 * Age 18 years and above * Male or female * Patients who have given consent and area able to follow the treatment given * Patients who are able to record their responses in survey form at regular follow-up visits Exclusion Criteria: * Patients who are in remission from ulcerative colitis, or who have a Partial Mayo Index Score of 0 or 1 * Patients who have been taking azathioprine or mercaptopurine for \<12 weeks for the treatment of their ulcerative colitis * Patients who are taking steroids or biologic agents for the treatment of their ulcerative colitis * Patients who have severe ulcerative colitis, or who have a Partial Mayo Index Score of 7 or above * Patients who are noncompliant with medication or regular follow up visits * Patients who are unable to or unwilling to record their responses in survey form * Patients with comorbid illnesses, including: Diabetes Mellitus, Stage III or above Congestive Heart Failure, chronic pancreatitis, severe liver or renal disease * Patients who have current gallstones or any biliary dysfunction * Patients with anemia (Hemoglobin \<10), thrombocytopenia, abnormal lymphocyte counts, or coagulation abnormalities * Patients who currently have an ongoing severe infection/sepsis * Patients with a history of malignancy * Patients who are currently pregnant or nursing * Patients who are current smokers